Randomized phase II, three-arm trial of lenvatinib (LEN), everolimus (EVE), and LEN+EVE in patients (pts) with metastatic renal cell carcinoma (mRCC) Meeting Abstract
| Authors: | Motzer, R.; Hutson, T.; Glen, H.; Michaelson, D.; Molina, A. M.; Eisen, T.; Jassem, J.; Zolnierek, J.; Maroto, P.; Mellado, B.; Melichar, B.; Tomasek, J.; Kim, H. J.; Wood, K.; Dutcus, C.; Larkin, J. M. G. |
| Abstract Title: | Randomized phase II, three-arm trial of lenvatinib (LEN), everolimus (EVE), and LEN+EVE in patients (pts) with metastatic renal cell carcinoma (mRCC) |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036900974 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.4506 |
| Notes: | Meeting Abstract: 4506 -- Source: Wos |
